There is a new UKMi Q&A – Is there a role for inhaled epoprostenol, inhaled nitric oxide or sildenafil to treat secondary pulmonary hypertension and hypoxaemia in ICU patients with acute respiratory distress syndrome?
To aid in the appropriate use of medicines during the current Coronavirus (COVID-19) pandemic, AWTTC have provided therapeutic advice for information on the AWTTC.org website.
There is an update to the UKMi Q&A: How should crusted and other forms of difficult-to-treat scabies be managed?
There is an update to the UKMi Q&A for Which commonly used nebuliser solutions are compatible?
There is an updated UKMi Q&A: Cannabidiol-oil-potential-adverse-effects
There is an updated UKMi Q&A – What is the most suitable treatment for acne in a patient with acute porphyria?
There is an updated UKMi Q&A – What is the risk of gastrointestinal bleeding associated with selective serotonin reuptake inhibitors (SSRIs)?
There is an updated UKMi Q&A – Cannabidiol oil – potential adverse effects
There is an updated UKMI Q&A – Are topical medicines safe in people with porphyria?
There is an updated UKMi Q&A – Is it safe for breastfeeding women to take herbal medicines?
